- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02513277
Diabetes Screening & Prevention for People With Learning (Intellectual) Disabilities:STOP Diabetes Study
Screening for Glucose Intolerance and Development of a Lifestyle Education Programme for Prevention of Type 2 Diabetes in a Population With Learning Disabilities
People with learning (intellectual) disabilities have more health problems than the rest of the population; they are less likely to access help and have lifestyles that may increase their risk of getting diabetes (for example, poor diet and lack of physical activity). People with learning disabilities may also be prescribed drugs or have certain medical conditions (such as Down's syndrome) which can make their chances of getting diabetes greater.
Diabetes is a long-term condition, which can cause damage to the eyes, heart, kidneys, nerves and feet. Impaired glucose regulation happens when sugar levels in the blood are higher than normal but are not high enough to be diagnosed with diabetes. People with impaired glucose regulation are more likely to develop diabetes, heart disease and stroke in the future. If people with impaired glucose regulation make changes to their lifestyle (diet and exercise) they can prevent or delay getting diabetes.
The aim of this study is to screen people with learning disabilities for diabetes and impaired glucose regulation. The investigators also want to find out the best way to give people with learning disabilities some education around healthy lifestyles (for example, eating and exercise) to help with prevention of diabetes and cardiovascular disease. Therefore, the investigators also aim to develop a lifestyle education programme that is suitable for use in this population and test whether it is feasible and acceptable.
Study Overview
Status
Detailed Description
Background -Adults with learning (intellectual) disabilities tend to have more health problems than the general population and are less likely to access help. Additionally, evidence suggests that due to a combination of lifestyle factors (e.g. poor diet, lack of physical activity), associated medical problems, and certain types of prescribed medication, people with learning disabilities may be at increased risk of developing type 2 diabetes and cardiovascular disease. Our overall aim is to undertake a programme of research that improves our knowledge and understanding of screening for impaired glucose regulation and type 2 diabetes in a population with learning disabilities, and to develop a lifestyle education programme for prevention of type 2 diabetes that is suitable for use in this population.
SCREENING PROGRAMME
Aim - The main programme of work consists of a large diabetes screening programme. The primary aim of the screening study is to evaluate the feasibility and clinical and cost effectiveness of a screening programme for identifying undiagnosed type 2 diabetes and impaired glucose regulation that is suitable for use in a population with learning disabilities.
Methods - A variety of approaches will be used to recruit people to the screening study: General practices will be approached first for participation in this study. If the practice does not agree, then the investigators will seek to approach eligible people on the Leicestershire Learning Disabilities Register. Learning disabilities consultants will also approach people face to face when attending for outpatient clinic appointments. Additionally, if individuals with learning disabilities (and/or their carer) contact the STOP Diabetes team to express an interest in the study, they will be given an invitation.
- Volunteers will be asked to attend an appointment(s) where consent will be obtained and biomedical and demographic data collected. The consent process and data collection will be staged and people may need to attend between one to three appointments to complete.
- People who are found to have type 2 diabetes or impaired glucose regulation will be asked to see their GP for care.
- At every stage, reasonable adjustments will be made to take into account people's communication needs and decision making capacity. This may include involving a carer or a
DEVELOPMENT AND TESTING OF A STRUCTURED EDUCATION PROGRAMME
The aims of additional work being carried out alongside the screening study are to: (1) develop a lifestyle education programme to meet the needs of a population with learning disabilities and impaired glucose regulation or high risk of diabetes; (2) assess the feasibility of collecting outcome measures for participants with learning disabilities before and 3-months after they attend the education programme.
Methods - People approached to take part will be people who took part in the screening study and (1) gave their consent to be approached to take part in further phases of the research programme, and (2) were found to be at increased risk of developing diabetes according to their screening results.
Qualitative Interviews to inform curriculum development:
- Interviews will be conducted with a sample of people with mild/moderate learning disabilities, their carers and healthcare professionals. Findings from the interviews will help inform development of an initial curriculum and education program.
Delivery of initial curriculum and obtaining feedback:
- As part of the development work the education programme will be piloted with at least two groups of 6 - 8 people plus carers. Feedback will be collected from some of the people who attend the education sessions and any necessary changes made to the curriculum. These cycles of piloting, collecting feedback and modifying the programme will be repeated until the education programme developed is "fit for purpose".
Delivery of programme with collection of before and after measures:
- Following initial development, testing and refinement of the curriculum, the education programme will be delivered with another sample of participants and the feasibility of collecting pre and post intervention outcome measures will be tested. The investigators anticipate delivering the programme to up to two groups of 6 - 8 people plus carers. Data will be collected at baseline and 3-months (12 weeks) following delivery of the final education session. Data and may include: physical activity and sedentary behaviour (as measured by accelerometer); body weight, BMI, waist circumference, blood pressure and dietary intake (fruit and vegetables). Uptake of the education programme (attendance) and retention at 3-months follow-up will also be explored. This phase will be subject to modification depending on the findings from prior iterations and any problems encountered.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Leicester, United Kingdom, LE5 4PW
- Diabetes Research Centre, University of Leicester
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Volunteer has a confirmed learning disability (permanent intellectual impairment);
- Registered with a general practice in Leicester, Leicestershire or Rutland, UK;
- Participant and/or carer has sufficient English language skills to enable fully informed consent to be obtained.
Exclusion Criteria:
- Confirmed diagnosis of Type 2 diabetes or Type 1 Diabetes;
- Malignancy or terminal illness;
- Pregnancy or breast feeding;
- Severe systemic disease that may interfere with measurement and interpretation of HbA1c.
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Glycosylated haemoglobin (HbA1c)
Time Frame: Baseline screening appointment
|
Identification of type 2 diabetes, impaired glucose regulation, or normal glucose regulation
|
Baseline screening appointment
|
Plasma glucose
Time Frame: Baseline screening appointment
|
Identification of type 2 diabetes, impaired glucose regulation, or normal glucose regulation
|
Baseline screening appointment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Physical activity levels (including sedentary behaviour)
Time Frame: Baseline screening appointment
|
measured by accelerometer - only for a small sub-group
|
Baseline screening appointment
|
Obesity levels
Time Frame: Baseline screening appointment
|
body mass index and waist size
|
Baseline screening appointment
|
Blood pressure
Time Frame: Baseline screening appointment
|
systolic and diastolic
|
Baseline screening appointment
|
Lipids levels
Time Frame: Baseline screening appointment
|
total cholesterol, LDL, HDL, triglycerides
|
Baseline screening appointment
|
Dietary/nutritional intake
Time Frame: Baseline screening appointment
|
food groups and fruit and vegetable intake
|
Baseline screening appointment
|
Cardiovascular risk
Time Frame: Baseline screening appointment
|
Framingham risk score
|
Baseline screening appointment
|
Health related quality of life
Time Frame: Baseline screening appointment
|
EQ-5D
|
Baseline screening appointment
|
Behavioural disorders
Time Frame: Baseline screening appointment
|
Aberrant Behaviour Checklist
|
Baseline screening appointment
|
Psychiatric disorders
Time Frame: Baseline screening appointment
|
PAS-ADD checklist
|
Baseline screening appointment
|
Depression
Time Frame: Baseline screening appointment
|
Glasgow Depression Scale and Carer Supplement
|
Baseline screening appointment
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Prof Kamlesh Khunti, PhD, FRCGP, Diabetes Research Centre, University of Leicester
- Principal Investigator: Prof Sabyasachi Bhaumik, FRCPsych, Learning Disability Service, Leicester Partnership NHS Trust
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Mental Disorders
- Glucose Metabolism Disorders
- Metabolic Diseases
- Nervous System Diseases
- Neurologic Manifestations
- Neurobehavioral Manifestations
- Endocrine System Diseases
- Neurodevelopmental Disorders
- Communication Disorders
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Prediabetic State
- Intellectual Disability
- Learning Disabilities
Other Study ID Numbers
- 0341
- RP-PG-1209-10057 (Other Grant/Funding Number: NIHR Programme Grant for Applied Research)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes Mellitus, Type 2
-
SanofiCompletedType 1 Diabetes Mellitus-Type 2 Diabetes MellitusHungary, Russian Federation, Germany, Poland, Japan, United States, Finland
-
Mannkind CorporationTerminatedType 2 Diabetes Mellitus | Type 1 Diabetes MellitusUnited States
-
Scripps Whittier Diabetes InstituteSan Diego State UniversityCompletedType 2 Diabetes Mellitus (T2DM)United States
-
RWTH Aachen UniversityBoehringer IngelheimCompletedDiabetes Mellitus Type 2 (T2DM)Germany
-
US Department of Veterans AffairsAmerican Diabetes AssociationCompletedType 2 Diabetes MellitusUnited States
-
Dexa Medica GroupCompletedType-2 Diabetes MellitusIndonesia
-
Griffin HospitalCalifornia Walnut CommissionCompletedDIABETES MELLITUS TYPE 2United States
-
University Hospital Inselspital, BerneCompletedType 2 Diabetes MellitusSwitzerland
-
India Diabetes Research Foundation & Dr. A. Ramachandran...CompletedTYpe 2 Diabetes MellitusIndia
-
AstraZenecaRecruiting